Dr. Harry P. Erba
Claim this profileDuke University Medical Center
Expert in Leukemia
Studies Acute Myeloid Leukemia
14 reported clinical trials
26 drugs studied
Area of expertise
1Leukemia
Global LeaderBCR-ABL1 positive
FLT3 positive
NPM1 positive
2Acute Myeloid Leukemia
FLT3 positive
NPM1 positive
KMT2A (MLL)-fusion positive
Affiliated Hospitals
Clinical Trials Harry P. Erba is currently running
DSP-5336
for Leukemia
This trial is testing a new drug called DSP 5336 to help treat adults with certain types of blood cancer that have come back or didn't respond to previous treatments. The study will first find the best amount to give and then check how safe and helpful it is.
Recruiting1 award Phase 1 & 215 criteria
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
More about Harry P. Erba
Clinical Trial Related5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Harry P. Erba has experience with
- Venetoclax
- MBG453
- Azacitidine
- Blinatumomab
- Cytarabine
- Uproleselan
Breakdown of trials Harry P. Erba has run
Leukemia
Acute Myeloid Leukemia
Myeloid Leukemia
Lymphoid Leukemia
Lymphoblastic Leukemia-Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Harry P. Erba specialize in?
Harry P. Erba focuses on Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Leukemia has involved BCR-ABL1 positive patients, or patients who are FLT3 positive.
Is Harry P. Erba currently recruiting for clinical trials?
Yes, Harry P. Erba is currently recruiting for 6 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Harry P. Erba has studied deeply?
Yes, Harry P. Erba has studied treatments such as Venetoclax, MBG453, Azacitidine.
What is the best way to schedule an appointment with Harry P. Erba?
Apply for one of the trials that Harry P. Erba is conducting.
What is the office address of Harry P. Erba?
The office of Harry P. Erba is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.